Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

OPUS GENETICS, INC. (IRD)

  • Business News
  • June 16, 2026, 20:05 UTC
  • 7
  • 1 comments

Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases

Market reaction Comment Full text

AMC NETWORKS INC. (AMCX)

  • Business News
  • June 16, 2026, 20:05 UTC
  • 3
  • 1 comments

AMC Global Media Appoints Hozefa Lokhandwala as Chief Financial Officer

Market reaction Comment Full text

CARETRUST REIT, INC. (CTRE)

  • Business News
  • June 16, 2026, 20:05 UTC
  • 6
  • 1 comments

CareTrust REIT Announces Quarterly Dividend of $0.39 per Share

Market reaction Comment Full text

HIGHWOODS PROPERTIES, INC. (HIW)

  • Business News
  • June 16, 2026, 20:05 UTC
  • 5
  • 1 comments

Highwoods to Release Second Quarter 2026 Results Tuesday, July 28th

Market reaction Comment Full text

ANNEXON, INC. (ANNX)

  • Business News
  • June 16, 2026, 20:05 UTC
  • 1
  • 1 comments

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 7
  • 1 comments

Rigel Announces Closing of Licensing Agreement forVEPPANU™ (vepdegestrant)

Market reaction Comment Full text

QUANTERIX CORP (QTRX)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 4
  • 1 comments

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

GALAPAGOS NV (LKFT)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 1
  • 1 comments

Acquisition of Own Shares

Market reaction Comment Full text

VERASTEM, INC. (VSTM)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 4
  • 1 comments

Verastem Oncology Doses First Patient in TARGET-D 201 Phase 2 Registration-Directed Trial of VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor for KRAS G12D-Mutated Metastatic Pancreatic Cancer

Market reaction Comment Full text

STOKE THERAPEUTICS, INC. (STOK)

  • Business News
  • June 16, 2026, 20:01 UTC
  • 1
  • 1 comments

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Market reaction Comment Full text
  • Previous
  • 2458
  • 2459
  • 2460
  • 2461
  • 2462
  • Next

Search

News categories

  • Technical Exchange News(14124)
  • Event(6229)
  • SEC News(359825)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(220036)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin